| 1. PubChem BioAssay data set, |
| 2. PubChem BioAssay data set, |
| 3. Sinha N, Sen S.. (2011) Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model., 46 (2): [PMID:21185626] [10.1016/j.ejmech.2010.11.042] |
| 4. Junio HA, Sy-Cordero AA, Ettefagh KA, Burns JT, Micko KT, Graf TN, Richter SJ, Cannon RE, Oberlies NH, Cech NB.. (2011) Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis)., 74 (7): [PMID:21661731] [10.1021/np200336g] |
| 5. Chen XB, Zhuang JJ, Liu JH, Lei M, Ma L, Chen J, Shen X, Hu LH.. (2011) Potential AMPK activators of cucurbitane triterpenoids from Siraitia grosvenorii Swingle., 19 (19): [PMID:21893415] [10.1016/j.bmc.2011.08.030] |
| 6. PubChem BioAssay data set, |
| 7. Shan WJ, Huang L, Zhou Q, Meng FC, Li XS.. (2011) Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation., 46 (12): [PMID:22019228] [10.1016/j.ejmech.2011.09.051] |
| 8. Park JE, Cuong TD, Hung TM, Lee I, Na M, Kim JC, Ryoo S, Lee JH, Choi JS, Woo MH, Min BS.. (2011) Alkaloids from Chelidonium majus and their inhibitory effects on LPS-induced NO production in RAW264.7 cells., 21 (23): [PMID:22024033] [10.1016/j.bmcl.2011.09.128] |
| 9. He H, Bai LP, Jiang ZH.. (2012) Synthesis and human telomeric G-quadruplex DNA-binding activity of glucosaminosides of shikonin/alkannin., 22 (4): [PMID:22281188] [10.1016/j.bmcl.2011.12.143] |
| 10. Maiti M, Nauwelaerts K, Herdewijn P.. (2012) Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing., 22 (4): [PMID:22257890] [10.1016/j.bmcl.2011.12.103] |
| 11. Kong D, Yamori T.. (2012) JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs., 20 (6): [PMID:22336246] [10.1016/j.bmc.2012.01.017] |
| 12. Krivogorsky B, Pernat JA, Douglas KA, Czerniecki NJ, Grundt P.. (2012) Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondii., 22 (8): [PMID:22425568] [10.1016/j.bmcl.2012.02.038] |
| 13. Huang L, Su T, Shan W, Luo Z, Sun Y, He F, Li X.. (2012) Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids., 20 (9): [PMID:22472046] [10.1016/j.bmc.2012.02.059] |
| 14. Tran TD, Do TH, Tran NC, Ngo TD, Huynh TN, Tran CD, Thai KM.. (2012) Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics., 22 (14): [PMID:22727643] [10.1016/j.bmcl.2012.05.112] |
| 15. Parhi A, Lu S, Kelley C, Kaul M, Pilch DS, LaVoie EJ.. (2012) Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivatives., 22 (22): [PMID:23058886] [10.1016/j.bmcl.2012.08.123] |
| 16. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P.. (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions., 55 (10): [PMID:22541068] [10.1021/jm300212s] |
| 17. Kelley C, Zhang Y, Parhi A, Kaul M, Pilch DS, LaVoie EJ.. (2012) 3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents., 20 (24): [PMID:23127490] [10.1016/j.bmc.2012.10.009] |
| 18. Chen Z, Ye X, Yi J, Chen X, Li X. (2012) Synthesis of 9-O-glycosyl-berberine derivatives and bioavailability evaluation, 21 (8): [10.1007/s00044-011-9678-1] |
| 19. Ramirez-Galicia G, Martinez-Pacheco H, Garduno-Juarez R, Deeb O. (2012) Exploring QSAR of antiamoebic agents of isolated natural products by MLR, ANN, and RTO, 21 (9): [10.1007/s00044-011-9767-1] |
| 20. Mohammad M, Al-masri IM, Issa A, Khdair A, Bustanji Y. (2013) Inhibition of pancreatic lipase by berberine and dihydroberberine: an investigation by docking simulation and experimental validation, 22 (5): [10.1007/s00044-012-0221-9] |
| 21. Zhang SL, Chang JJ, Damu GL, Fang B, Zhou XD, Geng RX, Zhou CH.. (2013) Novel berberine triazoles: synthesis, antimicrobial evaluation and competitive interactions with metal ions to human serum albumin., 23 (4): [PMID:23312473] [10.1016/j.bmcl.2012.12.036] |
| 22. Keffer JL, Huecas S, Hammill JT, Wipf P, Andreu JM, Bewley CA.. (2013) Chrysophaentins are competitive inhibitors of FtsZ and inhibit Z-ring formation in live bacteria., 21 (18): [PMID:23932448] [10.1016/j.bmc.2013.07.033] |
| 23. Wang Y, Zhou C, Chen J, Lin Y, Zeng W, Kuang B, Fu W, Chen W. (2013) Facile synthesis of a polyether-tethered dimeric berberine as a highly effective DNA-cleaving agent in the presence of Cu(ii) ion, 4 (10): [10.1039/C3MD00136A] |
| 24. PubChem BioAssay data set, |
| 25. Islam MM, Basu A, Suresh Kumar G. (2011) Binding of 9-O-(-amino) alkyl ether analogues of the plant alkaloid berberine to poly(A): insights into self-structure induction, 2 (7): [10.1039/C0MD00209G] |
| 26. Zhang S, Chang J, Damu GLV, Geng R, Zhou C. (2013) Berberine azoles as antimicrobial agents: synthesis, biological evaluation and their interactions with human serum albumin, 4 (5): [10.1039/C3MD00032J] |
| 27. Le Gresley A, Abdullah A, Chawla D, Desai P, Ghosh U, Gollapalli U, Kiran M, Lafon S, Sinclair A. (2011) Diacrylamides as selective G-quadruplex ligands in in vitro and in vivo assays, 2 (6): [10.1039/C1MD00020A] |
| 28. Cheng P, Zhou J, Qing Z, Kang W, Liu S, Liu W, Xie H, Zeng J.. (2014) Synthesis of 5-methyl phenanthridium derivatives: a new class of human DOPA decarboxylase inhibitors., 24 (12): [PMID:24794108] [10.1016/j.bmcl.2014.04.047] |
| 29. Kim JH, Ryu YB, Lee WS, Kim YH.. (2014) Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome., 22 (21): [PMID:25277281] [10.1016/j.bmc.2014.09.004] |
| 30. Li X, Ma S.. (2015) Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ., 95 [PMID:25791674] [10.1016/j.ejmech.2015.03.026] |
| 31. Nguyen VT, To DC, Tran MH, Oh SH, Kim JA, Ali MY, Woo MH, Choi JS, Min BS.. (2015) Isolation of cholinesterase and β-secretase 1 inhibiting compounds from Lycopodiella cernua., 23 (13): [PMID:26003344] [10.1016/j.bmc.2015.04.080] |
| 32. Takeda H, Ishikawa K, Wakana D, Fukuda M, Sato F, Hosoe T.. (2015) 11-Hydroxylation of Protoberberine by the Novel Berberine-Utilizing Aerobic Bacterium Sphingobium sp. Strain BD3100., 78 (12): [PMID:26654260] [10.1021/acs.jnatprod.5b00408] |
| 33. Son D, Kim CS, Lee KR, Park HJ.. (2016) Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay., 26 (9): [PMID:26996372] [10.1016/j.bmcl.2016.03.010] |
| 34. Kellogg JJ, Todd DA, Egan JM, Raja HA, Oberlies NH, Kvalheim OM, Cech NB.. (2016) Biochemometrics for Natural Products Research: Comparison of Data Analysis Approaches and Application to Identification of Bioactive Compounds., 79 (2): [PMID:26841051] [10.1021/acs.jnatprod.5b01014] |
| 35. Duggirala S, Napoleon JV, Nankar RP, Senu Adeeba V, Manheri MK, Doble M.. (2016) FtsZ inhibition and redox modulation with one chemical scaffold: Potential use of dihydroquinolines against mycobacteria., 123 [PMID:27517804] [10.1016/j.ejmech.2016.07.058] |
| 36. Wang J, Yang T, Chen H, Xu YN, Yu LF, Liu T, Tang J, Yi Z, Yang CG, Xue W, Yang F.. (2017) The synthesis and antistaphylococcal activity of 9, 13-disubstituted berberine derivatives., 127 [PMID:28092858] [10.1016/j.ejmech.2017.01.012] |
| 37. Luo X, Li C, Luo P, Lin X, Ma H, Seeram NP, Song C, Xu J, Gu Q.. (2016) Pterosin Sesquiterpenoids from Pteris cretica as Hypolipidemic Agents via Activating Liver X Receptors., 79 (12): [PMID:28006909] [10.1021/acs.jnatprod.6b00558] |
| 38. Lee H, Tuong LT, Jeong JH, Lee SJ, Bae GU, Ryu JH.. (2017) Isoquinoline alkaloids from Coptis japonica stimulate the myoblast differentiation via p38 MAP-kinase and Akt signaling pathway., 27 (6): [PMID:28228365] [10.1016/j.bmcl.2017.02.003] |
| 39. Zoidis G, Sosic A, Da Ros S, Gatto B, Sissi C, Palluotto F, Carotti A, Catto M.. (2017) Indenocinnoline derivatives as G-quadruplex binders, topoisomerase IIα inhibitors and antiproliferative agents., 25 (9): [PMID:28342691] [10.1016/j.bmc.2017.03.019] |
| 40. Dutour R, Poirier D.. (2017) Inhibitors of cytochrome P450 (CYP) 1B1., 135 [PMID:28458135] [10.1016/j.ejmech.2017.04.042] |
| 41. Hao M, Li Y, Liu L, Yuan X, Gao Y, Guan Z, Li W.. (2017) The design and synthesis of a novel compound of berberine and baicalein that inhibits the efficacy of lipid accumulation in 3T3-L1 adipocytes., 25 (20): [PMID:28818460] [10.1016/j.bmc.2017.08.013] |
| 42. Cai Z, Ding Z, Hao Y, Ni T, Xie F, Zhao J, Li R, Yu S, Wang T, Chai X, Jin Y, Gao Y, Zhang D, Jiang Y.. (2017) Design, synthesis, and SAR study of 3-(benzo[d][1,3]dioxol-5-yl)-N-benzylpropanamide as novel potent synergists against fluconazole-resistant Candida albicans., 27 (19): [PMID:28874321] [10.1016/j.bmcl.2017.08.053] |
| 43. Jeyakkumar P, Liu HB, Gopala L, Cheng Y, Peng XM, Geng RX, Zhou CH.. (2017) Novel benzimidazolyl tetrahydroprotoberberines: Design, synthesis, antimicrobial evaluation and multi-targeting exploration., 27 (8): [PMID:28302402] [10.1016/j.bmcl.2017.02.071] |
| 44. Seong SH, Ali MY, Kim HR, Jung HA, Choi JS.. (2017) BACE1 inhibitory activity and molecular docking analysis of meroterpenoids from Sargassum serratifolium., 25 (15): [PMID:28576634] [10.1016/j.bmc.2017.05.033] |
| 45. Singh SP, Sashidhara KV.. (2017) Lipid lowering agents of natural origin: An account of some promising chemotypes., 140 [PMID:28987600] [10.1016/j.ejmech.2017.09.020] |
| 46. Gao WW, Gopala L, Bheemanaboina RRY, Zhang GB, Li S, Zhou CH.. (2018) Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii., 146 [PMID:29396362] [10.1016/j.ejmech.2018.01.038] |
| 47. Khan H, Rengasamy KRR, Pervaiz A, Nabavi SM, Atanasov AG, Kamal MA.. (2018) Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation., 153 [PMID:29329790] [10.1016/j.ejmech.2017.12.059] |
| 48. Qiu S, Yang WZ, Yao CL, Shi XJ, Li JY, Lou Y, Duan YN, Wu WY, Guo DA.. (2017) Malonylginsenosides with Potential Antidiabetic Activities from the Flower Buds of Panax ginseng., 80 (4): [PMID:28345906] [10.1021/acs.jnatprod.6b00789] |
| 49. da Silva-Júnior EF, Leoncini GO, Rodrigues ÉES, Aquino TM, Araújo-Júnior JX.. (2017) The medicinal chemistry of Chikungunya virus., 25 (16): [PMID:28689975] [10.1016/j.bmc.2017.06.049] |
| 50. Enkhtaivan G, Muthuraman P, Kim DH, Mistry B.. (2017) Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase., 25 (20): [PMID:28958846] [10.1016/j.bmc.2017.07.006] |
| 51. Li C, Cheng B, Fang S, Zhou H, Gu Q, Xu J.. (2018) Design, syntheses and lipid accumulation inhibitory activities of novel resveratrol mimics., 143 [PMID:29172079] [10.1016/j.ejmech.2017.11.017] |
| 52. Duan JR, Liu HB, Jeyakkumar P, Gopala L, Li S, Geng RX, Zhou CH.. (2017) Design, synthesis and biological evaluation of novel Schiff base-bridged tetrahydroprotoberberine triazoles as a new type of potential antimicrobial agents., 8 (5): [PMID:30108806] [10.1039/C6MD00688D] |
| 53. Nasiri HR, Mracek P, Grimm SK, Gastaldello J, Kolodzik A, Ullmann D.. (2017) PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B., 8 (6): [PMID:30108832] [10.1039/C7MD00126F] |
| 54. Unpublished dataset, |
| 55. Zhang J, Ba Y, Wang S, Yang H, Hou X, Xu Z.. (2019) Nitroimidazole-containing compounds and their antibacterial and antitubercular activities., 179 [PMID:31260891] [10.1016/j.ejmech.2019.06.068] |
| 56. Santos ARN, Sheldrake HM, Ibrahim AIM, Danta CC, Bonanni D, Daga M, Oliaro-Bosso S, Boschi D, Lolli ML, Pors K.. (2019) Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity., 10 (8): [PMID:31673310] [10.1039/C9MD00201D] |
| 57. Fang Z, Zheng S, Chan KF, Yuan W, Guo Q, Wu W, Lui HK, Lu Y, Leung YC, Chan TH, Wong KY, Sun N.. (2019) Design, synthesis and antibacterial evaluation of 2,4-disubstituted-6-thiophenyl-pyrimidines., 161 [PMID:30347327] [10.1016/j.ejmech.2018.10.039] |
| 58. Mohd Siddique MU, Barbhuiya TK, Sinha BN, Jayaprakash V.. (2019) Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1., 163 [PMID:30503941] [10.1016/j.ejmech.2018.11.039] |
| 59. Ahn J, Kim YM, Chae HS, Choi YH, Ahn HC, Yoo H, Kang M, Kim J, Chin YW.. (2019) Prenylated Flavonoids from the Roots and Rhizomes of Sophora tonkinensis and Their Effects on the Expression of Inflammatory Mediators and Proprotein Convertase Subtilisin/Kexin Type 9., 82 (2): [PMID:30698432] [10.1021/acs.jnatprod.8b00748] |
| 60. Hostalkova A, Marikova J, Opletal L, Korabecny J, Hulcova D, Kunes J, Novakova L, Perez DI, Jun D, Kucera T, Andrisano V, Siatka T, Cahlikova L.. (2019) Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease., 82 (2): [PMID:30701972] [10.1021/acs.jnatprod.8b00592] |
| 61. Laudadio E, Cedraro N, Mangiaterra G, Citterio B, Mobbili G, Minnelli C, Bizzaro D, Biavasco F, Galeazzi R.. (2019) Natural Alkaloid Berberine Activity against Pseudomonas aeruginosa MexXY-Mediated Aminoglycoside Resistance: In Silico and in Vitro Studies., 82 (7): [PMID:31274312] [10.1021/acs.jnatprod.9b00317] |
| 62. Mortazavi H, Nikfar B, Esmaeili SA, Rafieenia F, Saburi E, Chaichian S, Heidari Gorji MA, Momtazi-Borojeni AA.. (2020) Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance., 187 [PMID:31821990] [10.1016/j.ejmech.2019.111951] |
| 63. Yang FX, Huang JP, Liu Z, Wang Z, Yang J, Tang J, Yu Z, Yan Y, Kai G, Huang SX.. (2020) Benwamycins A-G, Trialkyl-Substituted Benzene Derivatives from a Soil-Derived Streptomyces., 83 (1): [PMID:31904958] [10.1021/acs.jnatprod.9b00903] |
| 64. Bernatchez JA, Tran LT, Li J, Luan Y, Siqueira-Neto JL, Li R.. (2020) Drugs for the Treatment of Zika Virus Infection., 63 (2): [PMID:31549836] [10.1021/acs.jmedchem.9b00775] |
| 65. Zhang S, Wang X, Yin W, Liu Z, Zhou M, Xiao D, Liu Y, Peng D.. (2016) Synthesis and hypoglycemic activity of 9-O-(lipophilic group substituted) berberine derivatives., 26 (19): [PMID:27561717] [10.1016/j.bmcl.2016.08.027] |
| 66. Gao F, Zhang X, Wang T, Xiao J.. (2019) Quinolone hybrids and their anti-cancer activities: An overview., 165 [PMID:30660827] [10.1016/j.ejmech.2019.01.017] |
| 67. Wu S, Yu D, Liu W, Zhang J, Liu X, Wang J, Yu M, Li Z, Chen Q, Li X, Ye X.. (2020) Magnoflorine from Coptis chinese has the potential to treat DNCB-induced Atopic dermatits by inhibiting apoptosis of keratinocyte., 28 (2): [PMID:31859028] [10.1016/j.bmc.2019.115093] |
| 68. Papi F, Bazzicalupi C, Ferraroni M, Ciolli G, Lombardi P, Khan AY, Kumar GS, Gratteri P.. (2020) Pyridine Derivative of the Natural Alkaloid Berberine as Human Telomeric G4-DNA Binder: A Solution and Solid-State Study., 11 (5): [PMID:32435365] [10.1021/acsmedchemlett.9b00516] |
| 69. Ali S, Alamzeb M, Rashid MU, Setzer WN.. (2020) Effect of Temperature on 1H NMR Spectra, Antitrypanosomal Activity, Conformational Analysis, and Molecular Docking of Curine Derivatives from Berberis brevissima., 83 (5): [PMID:32364734] [10.1021/acs.jnatprod.9b00397] |
| 70. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 71. Liu Y,He S,Chen Y,Liu Y,Feng F,Liu W,Guo Q,Zhao L,Sun H. (2020) Overview of AKR1C3: Inhibitor Achievements and Disease Insights., 63 (20.0): [PMID:32463235] [10.1021/acs.jmedchem.9b02138] |
| 72. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
| 73. Li B, Li H, Zhu Z, Xiang C, Xu Z, Fan C, Zhao Y, Feng C, Sun H, Zhang Y, Cai T, Tang W, Zhu W.. (2021) Discovery of chiral N-2'-aryletheryl-1'-alkoxy-ethyl substituted arylisoquinolones with anti-inflammatory activity from the nucleophilic addition reactions of the thiophenols and oxazolinium., 222 [PMID:34119832] [10.1016/j.ejmech.2021.113583] |
| 74. Zhang N, Song D, Chen W, Zhang S, Zhang P, Zhang N, Ma S.. (2021) Modification of 5-methylphenanthridium from benzothiazoles to indoles as potent FtsZ inhibitors: Broadening the antibacterial spectrum toward vancomycin-resistant enterococci., 224 [PMID:34340044] [10.1016/j.ejmech.2021.113723] |
| 75. Li Y, Wen H, Ge X.. (2021) Hormesis Effect of Berberine against Klebsiella pneumoniae Is Mediated by Up-Regulation of the Efflux Pump KmrA., 84 (11.0): [PMID:34665637] [10.1021/acs.jnatprod.1c00642] |
| 76. Dickerhoff J, Brundridge N, McLuckey SA, Yang D.. (2021) Berberine Molecular Recognition of the Parallel MYC G-Quadruplex in Solution., 64 (21.0): [PMID:34677968] [10.1021/acs.jmedchem.1c01508] |
| 77. Sun H, Huang SY, Jeyakkumar P, Cai GX, Fang B, Zhou CH.. (2022) Natural Berberine-derived Azolyl Ethanols as New Structural Antibacterial Agents against Drug-Resistant Escherichia coli., 65 (1.0): [PMID:34964345] [10.1021/acs.jmedchem.1c01592] |
| 78. Alharthi S, Ziora ZM, Moyle PM.. (2021) Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition., 52 [PMID:34839159] [10.1016/j.bmc.2021.116527] |
| 79. Fu DJ, Li J, Yu B.. (2021) Annual review of LSD1/KDM1A inhibitors in 2020., 214 [PMID:33581557] [10.1016/j.ejmech.2021.113254] |
| 80. Mangiaterra G, Cedraro N, Laudadio E, Minnelli C, Citterio B, Andreoni F, Mobbili G, Galeazzi R, Biavasco F.. (2021) The Natural Alkaloid Berberine Can Reduce the Number of Pseudomonas aeruginosa Tolerant Cells., 84 (4.0): [PMID:33848161] [10.1021/acs.jnatprod.0c01151] |
| 81. Su J, Zhai Q, Wei D.. (2022) Recent advancement in small molecules as HCV inhibitors., 60 [PMID:35278819] [10.1016/j.bmc.2022.116699] |
| 82. Fan T, Cheng Y, Wei W, Zeng Q, Guo X, Guo Z, Li Y, Zhao L, Shi Y, Zhang X, Jiang J, Wang Y, Kong W, Song D.. (2022) Palmatine Derivatives as Potential Antiplatelet Aggregation Agents via Protein Kinase G/Vasodilator-Stimulated Phosphoprotein and Phosphatidylinositol 3-Kinase/Akt Phosphorylation., 65 (10.0): [PMID:35549263] [10.1021/acs.jmedchem.2c00592] |
| 83. Ansari MF, Tan YM, Sun H, Li S, Zhou CH.. (2022) Unique iminotetrahydroberberine-corbelled metronidazoles as potential membrane active broad-spectrum antibacterial agents., 76 [PMID:36182008] [10.1016/j.bmcl.2022.129012] |
| 84. Liao M, Zhang J, Wang G, Wang L, Liu J, Ouyang L, Liu B.. (2021) Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions., 64 (5.0): [PMID:33650861] [10.1021/acs.jmedchem.0c01180] |
| 85. Buroni S, Makarov V, Scoffone VC, Trespidi G, Riccardi G, Chiarelli LR.. (2020) The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens., 190 [PMID:32066012] [10.1016/j.ejmech.2020.112132] |
| 86. Yang L, Yu S, Yang Y, Wu H, Zhang X, Lei Y, Lei Z.. (2021) Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice., 55 [PMID:34979291] [10.1016/j.bmc.2021.116598] |
| 87. Ha S, Luo G, Xiang H.. (2022) A Comprehensive Overview of Small-Molecule Androgen Receptor Degraders: Recent Progress and Future Perspectives., 65 (24.0): [PMID:36459083] [10.1021/acs.jmedchem.2c01487] |
| 88. Ferreira JPS, Albuquerque HMT, Cardoso SM, Silva AMS, Silva VLM.. (2021) Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)., 221 [PMID:33984802] [10.1016/j.ejmech.2021.113492] |
| 89. Villarroel-Vicente C, Gutiérrez-Palomo S, Ferri J, Cortes D, Cabedo N.. (2021) Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview., 221 [PMID:33992930] [10.1016/j.ejmech.2021.113535] |
| 90. Singh S, Pathak N, Fatima E, Negi AS.. (2021) Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine., 226 [PMID:34536668] [10.1016/j.ejmech.2021.113839] |
| 91. Chen J, Duan Y, Yang K, Wang J, Yan J, Gu C, Wang S, Zhu Z, Liu EH, Xu J.. (2023) Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agents., 79 [PMID:36640595] [10.1016/j.bmc.2023.117156] |
